News

CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Biogen Inc. for the use of CEVEC’s proprietary ELEVECTA® Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. Under the terms of the agreement, CEVEC...

Encouraged by the recent approval by Drug Control General of India (DCGI) for its Covid-19 vaccine, Bharat Biotech is now gearing up for conducting the phase-1 clinical trial for its new intranasal antidote to beat the deadly spreading coronavirus. While...

Kite, a Gilead Company, and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies, announced that the companies have entered into a research collaboration to evaluate five novel...

Taysha Gene Therapies announced that it has joined with Catalent, a pharmaceutical services provider, to support production of its potential gene therapies for disorders that include CLN1 Batten disease and Rett syndrome. “Through this partnership, we will be able to...

STA Pharmaceutical, a WuXi AppTec Company (WuXi STA), announces their partner Innocare has received approval by the National Medical Products Administration of China (NMPA) for Orelabrutinib. Under the Marketing Authorization Holder (MAH) policy, WuXi STA provided an integrated and...

SPANISH contract development and manufacturing organisation (CDMO) Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento SA. Bringing with him the benefit of over 25 years of experience in the pharmaceutical and fine chemical industry,...

With the Drug Controller General of India (DCGI) approving Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving way for their roll-out and administration to millions, Russian Sputnik V vaccine makers have said that...